Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hutchmed Share News (HCM)
HCM Share
Price
HCM Share
News
HCM Share
Chat
HCM Share
Trades8
HCM
Live RNS
HCM Share
Charts
HCM Level 2
Console
HCM Live
Share Price
HCM Broker
Ratings
HCM Directors
Deals
HCM Financial
Diary
HCM
Fundamentals
HCM Short
Positions
HCM
Media
HCM Company
Research
HCM Company
Timeline
Share Price Information for Hutchmed (HCM)
Last checked at -
Last checked at 
Intraday Hutchmed Share Chart
Hutchmed News
Hutchmed celebrates cancer drug approval in hometown of Hong Kong
(Alliance News) - Hutchmed (China) Ltd on Tuesday touted progress in Hong Kong, after its oral therapy for metastatic colorectal cancer received marke...
Hutchmed application for thrombocytopenia treatment accepted in China
(Sharecast News) - Hutchmed China announced on Thursday that the new drug application (NDA) for sovleplenib, an oral inhibitor targeting spleen tyrosi...
TOP NEWS: Hutchmed Sovleplenib accepted for review by China drug bureau
(Alliance News) - Hutchmed Ltd on Thursday said that its novel treatment for haematological malignancies and immune diseases had been progressed to th...
IN BRIEF: Hutchmed China renews deals with "substantial" shareholders
Hutchmed (China) Ltd - Hong Kong-based developer of treatments for cancer and immunological diseases - Agrees with "substantial shareholder" Sinopharm...
Hutchmed completes enrolment for fruquintinib trial
(Alliance News) - Hutchmed (China) Ltd on Wednesday said it has completed enrolment of its phase II/III trial of fruquintinib.
Hutchmed completes trial enrolment, keeps drugs on China funding list
(Sharecast News) - Hutchmed China announced a significant milestone in its clinical trials on Wednesday, as well as the inclusion of two of its drugs ...
Hutchmed completes trial enrolment, keeps drugs on China funding list
(Sharecast News) - Hutchmed China announced a significant milestone in its clinical trials on Wednesday, as well as the inclusion of two of its drugs ...
Hutchmed hails Takeda's fruquintinib approval from US for cancer form
(Alliance News) - Hutchmed (China) Ltd on Thursday announced that the Tokyo-based drug maker, Takeda Pharmaceutical Co Ltd, has received US approval o...
Follow the stocks
